article thumbnail

Doctor Reveals What Happens When You Stop Taking Ozempic

AuroBlog - Aurous Healthcare Clinical Trials blog

Semaglutide (sold as Wegovy and Ozempic) and tirzepatide (sold as Zepbound and Mounjaro) are the most well known in the class of drugs that mimic hormones to reduce feelings of hunger. Drugs like Ozempic are very effective at helping most people who take them lose weight. But does weight come back when you stop using […]

Doctors 154
article thumbnail

Florida doctors' board tightens ban on gender-affirming care

Medical Xpress

A prohibition against puberty blocking hormones and gender-affirming surgeries for minors in Florida was tightened further after a board overseeing doctors eliminated an exception for clinical trials Friday at the request of Florida Gov. Ron DeSantis' administration.

Doctors 94
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Pharmalittle: Merck ends late-stage trial for Keytruda in prostate cancer; doctor group says 60 Minutes segment on Wegovy was an ad

STAT News

… Merck is discontinuing a late-stage trial of its blockbuster immunotherapy Keytruda in some prostate cancer patients after interim data showed it was unlikely to meet the study’s main goals , Reuters writes. The Our choice today is peppermint mocha. Meanwhile, here are a few items of interest.

Doctors 98
article thumbnail

A treatment for a deadly condition in newborns fails to improve outcomes, study finds

STAT News

For babies born with hypoxic-ischemic encephalopathy, commonly called birth asphyxia, doctors have limited options. A new study , published Wednesday in the New England Journal of Medicine, found that the hormone erythropoietin did not improve survival and other outcomes in newborns with hypoxic-ischemic encephalopathy.

article thumbnail

Sanofi takes a hit as hotly tipped breast cancer drug fails trial

pharmaphorum

Shares in Sanofi were on the slide this morning after the drugmaker revealed that one of its top pipeline prospects – selective oestrogen receptor degrader (SERD) amcenestrant – stumbled in a mid-stage breast cancer trial. The post Sanofi takes a hit as hotly tipped breast cancer drug fails trial appeared first on.

Trials 64
article thumbnail

FDA Approves Orgovyx (relugolix) as the First Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer

The Pharma Data

FDA Approves Orgovyx (relugolix) as the First Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer. Orgovyx, which was granted Priority Review by the FDA, is the first and only oral gonadotropin-releasing hormone (GnRH) receptor antagonist for men with advanced prostate cancer.

article thumbnail

Migraines and Menopause: What Women Need to Know

DM Clinical Research

We’ll also explain what’s normal- and when to see a doctor. How Hormones Affect Migraine Headaches. A woman’s hormones will become unpredictable leading up to menopause, which can cause unpredictable headaches. A doctor can prescribe a variety of medications to treat your migraines. Consider a Clinical Trial.